Systemic administration of bevacizumab increases the risk...

Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer

Christodoulos Stefanadis, Andreas Synetos, Dimitris Tousoulis, Eleftherios Tsiamis, Archontoula Michelongona, Flora Zagouri, Aristotle Bamias, Meletios Athanasios Dimopoulos, Stella Kyvelou, Ioannis K
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
154
Year:
2012
Language:
english
DOI:
10.1016/j.ijcard.2011.10.115
File:
PDF, 161 KB
english, 2012
Conversion to is in progress
Conversion to is failed